Medifast MED Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $346.1M-10.3% | $385.79M-10.2% | $429.7M-10.6% | $480.45M-11.6% | $543.45M-9.8% | ||
| $103.41M-6.5% | $110.6M-6.6% | $118.43M-5.8% | $125.67M-11.4% | $141.88M-10.1% | ||
| $242.7M-11.8% | $275.19M-11.6% | $311.27M-12.3% | $354.78M-11.7% | $401.58M-9.7% | ||
| 70.1%-1.2pp | 71.3%-1.1pp | 72.4%-1.4pp | 73.8%0.0pp | 73.9%+0.1pp | ||
| $258.94M-10.5% | $289.4M-8.7% | $316.97M-10.5% | $354.3M-13.1% | $407.9M-7.7% | ||
| $14.45M+1.4% | $14.24M+2.0% | $13.96M+1.9% | $13.7M+7.7% | $12.73M+0.1% | ||
| -$16.25M-14.3% | -$14.21M-149% | -$5.7M-1,270% | $487K+108% | -$6.32M-320% | ||
| -4.7%-1.0pp | -3.7%-2.4pp | -1.3%-1.4pp | 0.1%+1.3pp | -1.2%-1.6pp | ||
| —— | —— | —— | —— | —— | ||
| $8.14M-5.1% | $8.57M+11.1% | $7.72M+33.8% | $5.77M+708% | -$948K-204% | ||
| -$8.11M-43.8% | -$5.64M-379% | $2.02M-67.7% | $6.25M+186% | -$7.27M-292% | ||
| $11.92M-8.6% | $13.03M+636% | $1.77M-32.3% | $2.62M+1,051% | -$275K-116% | ||
| -$20.02M-7.2% | -$18.67M-7,629% | $248K-93.2% | $3.64M+152% | -$7M-434% | ||
| -5.8%-0.9pp | -4.8%-4.9pp | 0.1%-0.7pp | 0.8%+2.0pp | -1.3%-1.6pp | ||
| -$1.83-7.0% | -$1.71-17,200% | $0.01-96.9% | $0.32+149% | -$0.65-461% | ||
| -$1.82-7.1% | -$1.70-8,600% | $0.02-93.9% | $0.33+151% | -$0.65-461% | ||
| 44M+0.1% | 44M0.0% | 44M0.0% | 43.9M+0.3% | 43.8M0.0% | ||
| 44M+0.1% | 43.9M+0.1% | 43.9M+0.1% | 43.8M+0.1% | 43.8M+0.1% | ||
| -$669K-4,035% | $17K+105% | -$341K+85.4% | -$2.34M+60.4% | -$5.91M-44.4% | ||
| $11.44M-0.2% | $11.46M+240% | -$8.17M-10.2% | -$7.41M+1.1% | -$7.5M-1.2% | ||
| -$1.05M+23.6% | -$1.37M-32.1% | -$1.04M-140% | -$433K+6.5% | -$463K-420% | ||
| —— | —— | —— | —— | —— | ||
| -$19.37M+19.0% | -$23.91M+22.4% | -$30.83M+11.0% | -$34.66M-38.2% | -$25.07M+28.4% | ||
| -$8.16M-19.7% | -$6.81M-283% | $3.72M-11.8% | $4.22M-47.9% | $8.1M-20.7% | ||
| -$17.96M+19.1% | -$22.19M— | —— | —— | —— | ||
| $1.89M-13.8% | $2.2M+1,564% | -$150K-227% | $118K+136% | -$331K+16.4% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | -$569K+3.1% | -$587K+61.3% | ||
| -$23.01M-190% | -$7.93M+64.6% | -$22.41M-126% | -$9.91M+61.6% | -$25.8M+2.7% | ||
| —— | —— | —— | —— | —— | ||
| $2.55M-16.7% | $3.06M+14.5% | $2.67M+229% | $811K+114% | -$5.83M-49.7% | ||
| —— | —— | —— | $196K-1.5% | $199K-72.2% | ||
| $118.74M+40.7% | $84.41M+14.5% | $73.74M+22.9% | $60.01M+14.5% | $52.42M+12.5% | ||
| $5.19M-7.6% | $5.61M-14.3% | $6.55M-0.4% | $6.58M-7.8% | $7.14M-4.3% | ||
| $97.28M+18.5% | $82.09M+41.8% | $57.88M+2.1% | $56.68M+67.9% | $33.75M+22.6% | ||
| $346.1M-10.3% | $385.79M-10.2% | $429.7M-10.6% | $480.45M-11.6% | $543.45M-9.8% | ||
| $7.61M-0.4% | $7.64M+0.5% | $7.6M+4.2% | $7.3M+2.4% | $7.12M-3.3% | ||
| -$16.25M-14.3% | -$14.21M-149% | -$5.7M-1,270% | $487K+108% | -$6.32M-320% | ||
| -$1.8M-6,100% | $30K-99.6% | $8.26M-41.8% | $14.19M+122% | $6.4M-58.9% | ||
| -$1.8M-6,100% | $30K-99.6% | $8.26M-41.8% | $14.19M+122% | $6.4M-58.9% | ||
| -0.5%-0.5pp | 0%-1.9pp | 1.9%-1.0pp | 3%+1.8pp | 1.2%-1.4pp | ||
| -$16.25M-14.3% | -$14.21M-149% | -$5.7M-1,270% | $487K+108% | -$6.32M-320% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Medifast's revenue?
- Medifast (MED) generated $346.1M in revenue over the trailing twelve months, down 36.3% year over year.
- Is Medifast profitable?
- Medifast is not currently profitable: it reported a net loss of $20.0M over the trailing twelve months, a -5.8% net margin.
- What are Medifast's profit margins?
- Gross margin is 70.1% and operating margin is -4.7%, with a -5.8% net margin.
- What is Medifast's earnings per share?
- Medifast's diluted EPS over the trailing twelve months is $-1.83.
- Where does Medifast's income statement data come from?
- Every line is extracted from Medifast's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
